Investigators put forth a list of considerations for surgeons ahead of lens removalin paediatric patients
News
Plasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease
Investigators reported findings from the first study of successful macular hole closure using topical therapy
Investigators assessed the XEN45 implant alone and in combination with phacoemulsification
Early results indicate that trained optometrists delivered safe and effective laser treatments
The flagship, light-based technology has received approval for applications in the anterior and posterior segments
Surgeons shared practical pearls in a “Cataract Olympiad"
This year’s meeting will take place in Ireland’s technology and business hub
Three approaches to examination give a comprehensive overview
The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)
The light-based therapy functions using a virtual reality headset
Challenging choices force ophthalmologists to weigh long-term outcomes
Inhibiting ferroptosis could be crucial to reducing inflammation
Analysis of the OAKS and DERBY trials showed reduced growth rates of SD-OCT biomarkers for geographic atrophy
Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress
The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen
For decoding biomarkers, a multistage system is just the beginning
Need for accuracy results in optimisation of training for novice surgeons
The implantable lenses can offer an advantage over laser surgery
Promising innovations are not one-size-fits-all
The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March
Three leaders in glaucoma research, retina care and refractive surgery share their expertise
Astigmatic values differed between K and TK readings
Considering ages and stages of myopia progression in a therapeutic timeline
The mutant huntingtin protein in tear fluid may have the potential to serve as an early marker of changes in Huntington disease
Advertisement
Advertisement
